Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy

被引:96
作者
Vasankari, T [1 ]
Ahotupa, M
Toikka, J
Mikkola, J
Irjala, K
Pasanen, P
Neuvonen, K
Raitakari, O
Viikari, J
机构
[1] Paavo Nurmi Ctr, Sports Med Res Unit, Turku, Finland
[2] Univ Turku, Dept Physiol, MCA Res Lab, Turku 20520, Finland
[3] Univ Turku, Cent Hosp, Dept Clin Physiol, Turku, Finland
[4] Univ Turku, Cent Hosp, Dept Radiol, Turku, Finland
[5] Univ Turku, Cent Hosp, Dept Clin Chem, Turku, Finland
[6] Univ Turku, Dept Chem, Turku, Finland
[7] Univ Turku, Cent Hosp, Dept Med, FIN-20520 Turku, Finland
关键词
atherosclerosis; coronary angiography; diene conjugation; LDL oxidation; statins;
D O I
10.1016/S0021-9150(00)00573-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the relation between serum lipids including oxidized LDL and the severity of coronary atherosclerosis. Serum lipids and oxidized LDL was measured in 62 men (33-66 years), who underwent diagnostic coronary angiography and sonography to measure the carotid intima-media thickness. LDL oxidation was found in chemical analyses to be due to conjugated fatty acids in cholesteryl esters and triglycerides. Regression analysis indicated that the carotid intima-media thickness and the ratio of LDL diene conjugation to LDL cholesterol (the ox-LDL:LDL ratio) were the only factors associated independently with the severity of coronary atherosclerosis, The patients with multi-vessel disease who did not use lipid lowering therapy had a 50% thicker carotid intima media (P = 0.030) and a 41% higher ox-LDL:LDL ratio (P = 0.020) than patients with normal vessels. Further. patients with multi-vessel disease on statin therapy had a 24% lower ox-LDL:LDL ratio than the subjects with multi-vessel disease who did not use lipid lowering drugs (P = 0.027). although the concentration of LDL cholesterol did not differ between the groups. This study supports the hypothesis that lipid oxidation plays a role in the development of atherosclerosis. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 43 条
[1]   Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins [J].
Ahotupa, M ;
Ruutu, M ;
Mantyla, E .
CLINICAL BIOCHEMISTRY, 1996, 29 (02) :139-144
[2]   Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation [J].
Ahotupa, M ;
Marniemi, J ;
Lehtimäki, T ;
Talvinen, K ;
Raitakari, OT ;
Vasankari, T ;
Viikari, J ;
Luoma, J ;
Ylä-Herttuala, S .
CLINICAL BIOCHEMISTRY, 1998, 31 (04) :257-261
[3]   Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans [J].
Anderson, TJ ;
Meredith, IT ;
Charbonneau, F ;
Yeung, AC ;
Frei, B ;
Selwyn, AP ;
Ganz, P .
CIRCULATION, 1996, 93 (09) :1647-1650
[4]   SERUM ANTIBODIES TO OXIDIZED LOW-DENSITY-LIPOPROTEIN IN PREECLAMPSIA AND CORONARY HEART-DISEASE [J].
ARMSTRONG, VW ;
WIELAND, E ;
DIEDRICH, F ;
RENNER, A ;
RATH, W ;
KREUZER, H ;
KUHN, W ;
OELLERICH, M .
LANCET, 1994, 343 (8912) :1570-1570
[5]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[6]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[7]   DETECTION OF AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEINS AND OF IGG-BOUND LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
BOULLIER, A ;
HAMON, M ;
WALTERSLAPORTE, E ;
MARTINNIZART, F ;
MACKEREEL, R ;
FRUCHART, JC ;
BERTRAND, M ;
DURIEZ, P .
CLINICA CHIMICA ACTA, 1995, 238 (01) :1-10
[8]  
DEVARAJ S, 1997, HDB LIPOPROTEIN TEST, P357
[9]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[10]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75